Background Missing data are unavoidable in most randomized controlled clinical trials, especially when measurements are taken repeatedly. If strong assumptions about the missing data are not accurate, crude statistical analyses are biased and can lead to false inferences. Furthermore, if we fail to measure all predictors of missing data, we may not be able to model the missing data process sufficiently. In longitudinal randomized trials, measuring a patient's intent to attend future study visits may help to address both of these problems. Leon et al. developed and included the Intent to Attend assessment in the Lithium Treatment -Moderate dose Use Study (LiTMUS), aiming to remove bias due to missing data from the primary study hypothesis.
Introduction
In an ideal randomized controlled clinical trial, a crude statistical analysis will accurately measure the causal effect of interest. Investigators seek effective randomization, full compliance with the assigned intervention, and no missing data. Any deviation from these conditions results in statistical complications. Among these conditions, missing data can bias results the most. Missing data will not only reduce statistical power but also could lead to false inferences regarding the study hypothesis if the data are missing not at random; thus, it is crucial to consider some form of adjustment in the analysis.
Andrew C. Leon et al. [1] proposed a simple assessment, which measures a patient's intent to attend upcoming study visits. The Intent to Attend item was first implemented in the Lithium Treatment -Moderate dose Use Study (LiTMUS), a prospective randomized comparative effectiveness study. We evaluate its use in LiTMUS as well as suggest a simple method of adjustment using the Intent to Attend measure along with inverse probability of attrition weighting (IPAW). Both the assessment and the adjustment method are broadly applicable and add little burden to a randomized trial.
In this article, we first briefly discuss the complexities of missing data, the method of IPAW, and the rationale for measuring a patient's intent to attend future study visits. Second, we present the methods and results of implementing the Intent to Attend assessment in LiTMUS. We evaluate whether selfrated intentions predicted missed visits and detail a method to use intent in the context of IPAW. Finally, we discuss the limitations, strengths, and implications of this analysis.
Background
Missing data are inevitable in almost all randomized trials across medical research. If the data are missing completely at random, we do not have to adjust for the missing data mechanism. If the data are missing at random, it is common for investigators to use likelihood-based methods, such as mixed-effects regression, since the specification of the missing data mechanism can be ignored [2] . Unfortunately, the assumption of ignorable missing data cannot be empirically proven, and thus, there is no way to ascertain its validity. Therefore, it is important to carry out a sensitivity analysis to determine possible causes of missing data and the degree to which it may impact the results of a randomized trial.
Robins et al. [3, 4] as well as Hernán and colleagues [5] have proposed inverse probability of censoring weights to adjust for informative censoring in longitudinal observational studies. These weights have also been referred to as IPAW [6] . An advantage of IPAW is its conceptual simplicity. Specifically, each observation is weighted by its cumulative inverse probability of remaining in the study. For example, if a majority of patients from a subgroup (based on some common characteristics) dropped out before the second study visit, we would increase the weight of future observations of those remaining from this subgroup to account for those who were missing. These weights can be considered the number of copies of each observation that are necessary to create a pseudo-population in which all outcome measurements are observed [5] .
To estimate the weights, Hernán et al. [5] suggest using all relevant baseline and time-varying covariates that will help to predict missed visits. The Intent to Attend item, or one's intention to remain in the study, seems an ideal assessment to predict one's probability of retention. Moreover, some randomized trials do not (or cannot) measure all predictors of missed study visits. In these cases, the Intent to Attend item could act as a surrogate for any unmeasured covariates. It is this unique feature that sets the Intent to Attend item apart from other predictors and warrants its inclusion in a sensitivity analysis of missing data.
Several investigators have proposed using a participant's self-rated intent as a way to adjust for informative missing data [1, 7, 8] . Leon et al. [1] used a simulation study to evaluate the performance of a linear mixed model while accounting for a time-varying intent measure. They found the group effect and group-by-time interaction to be more accurately estimated when previous intent was included as a covariate. Although their results have positive implications, covariate adjustment has been shown to lead to biased inferences in certain instances [6, 9] . Moreover, in contrast to IPAW, parametric likelihood-based methods, such as mixed-effects regression, are much more Intent to Attend in a randomized trial 495 sensitive to model misspecification [3] . Therefore, using a patient's intent in the context of IPAW maintains the primary aim of measuring this variable, yet avoids certain shortcomings of covariate adjustment.
Methods

Study population and clinical assessments
Bipolar disorder is a psychiatric illness in which patients experience severe mood and behavioral swings, usually categorized as manic, hypomanic, or depressive episodes. Lithium has been a standard first-line medication option for bipolar disorder; however, its efficacy in combination with other medications remained uncertain.
LiTMUS was a 6-month multi-site randomized trial designed to test the effectiveness of adding moderate doses of lithium to optimized treatment of patients with bipolar disorder. A total of 283 study participants were randomized to receive either lithium plus optimized treatment or optimized treatment only. Optimized treatment consisted of guideline-informed personalized treatments to address individuals' symptoms and side effects [10] . One of the co-primary hypotheses was that patients randomized to adjunct lithium would experience greater improvement in bipolar severity as assessed with the Clinical Global Impressions scale for use in Bipolar Disorder. At each study visit (nine visits including baseline), patients were assessed by trained raters, their clinicians, and self-rated symptoms, side effects, and functioning. In LiTMUS, patients were allowed to remain in the study even if visits were missed; thus, the frequency of missing data was expected to remain low compared to other clinical trials among bipolar patients [11] . The rationale and design of LiT-MUS are discussed elsewhere [12] . In the primary analysis, there was no statistically significant advantage of adding moderate-dose lithium to optimized treatment regarding bipolar severity [13] .
We briefly describe the clinical assessments to which we refer in our analyses. The Clinical Global Impressions scale for use in Bipolar Disorder [14] includes a severity rating for overall bipolar illness. The severity score ranges from 1 to 7, where 1 is 'Normal, not ill' and 7 is 'Very severely ill'. Bipolar mood symptoms were measured using the Montgomery-Asberg Depression Rating Scale [15] and the Young Mania Rating Scale [16] . These two scales range from 0 to 60, where a higher score represents more severe symptoms. All measures of symptom severity were administered by trained raters.
Other patient characteristics that were measured include quality of life (Quality of Life Enjoyment and Satisfaction Questionnaire) [17] , psychosocial functioning (Range of Impaired Functioning Tool) [18] , substance abuse comorbidity (Substance Use Disorder Module of the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition (DSM-IV)) [19] , and impulsivity (Impulsivity Rating Scale) [20] . The Quality of Life Enjoyment and Satisfaction Questionnaire is a self-reported measure that ranges from 0 to 100; higher scores reflect higher quality of life. The Range of Impaired Functioning Tool is a clinicianadministered measure that ranges from 4 to 20, with higher scores indicating more impairment. The substance use interview assessed whether patients met certain threshold diagnosis criteria for different types of substance abuse (we dichotomized as any substance abuse versus none). The Impulsivity Rating Scale is a 7-item clinician-rated assessment that ranges from 0 to 21, wherein higher scores indicate higher impulsivity. We also, of course, measured a patient's intent to attend subsequent study visits.
Intent to Attend and missing data
In LiTMUS, the Intent to Attend item was implemented as designed by Leon et al. [1] (see Figure 1 ). At each study visit, patients rated the likelihood that they would attend the next study visit on an ordinal scale from 0 to 9: 0 being a low likelihood, or intent, to return and 9 corresponding to high intent.
We generated summary statistics and histograms to determine the distribution of intent among study participants. We also determined the frequency of missing outcome data in LiTMUS and whether it was monotonic (e.g., once missing, patient never returned) or intermittent (e.g., returned after missing a study visit). To test our hypothesis that the Intent to Attend would predict actual study attendance, we used generalized estimating equations (GEEs) to fit the following marginal model
The dependent variable was a binary indicator of whether a patient's outcome was observed (R = 1) or missing (R = 0). We included time, T j , defined as the scheduled visit week, and a patient's intent at the previous study visit (X i(j21) ). We assumed a logit link function, a Bernoulli variance, and an independent working correlation structure. Using the empirical standard error estimates, we tested whether the intent-by-time interaction was significant. If the interaction was not significant, it was removed, and the marginal effect of intent on missing the subsequent visit was tested.
IPAW
We used IPAW to account for potential informative missing data in LiTMUS. This method involved fitting two separate models: the missing data model and the outcome model.
IPAW missing data model
The missing data model was used to calculate the observation-specific stabilized weights [5] . The general specification of the stabilized weights is the following:
For each scheduled visit, R ij indicates whether patient i's outcome was observed at time j. The numerator of these weights is conditional on a patient's entire history of missed visits, up to and including the most recent scheduled visit (R i(jÀ1) ), any baseline covariates thought to predict missed visits (V i ), and time (T j ). In addition to these three variables, the denominator is also conditional on a patient's entire intent history, up to the most recent visit (I i(jÀ1) ), and any other time-varying covariate histories thought to predict missed visits (L i(jÀ1) ).
Our first missing data model was the simplest, and assumed that a patient's randomized treatment group, intent history, and history of bipolar severity predicted subsequent absence. Additionally, we assumed that a patient's presence or absence at the previous visit predicted whether the current visit was missed. This approach is similar to that of Preisser et al. [21] , allowing us to address the intermittent missing data, although resulting in stronger assumptions about the missing outcomes (see 'Discussion'). In the second model, we added the following baseline and time-varying covariates: gender, age, education status, quality of life, psychosocial functioning, substance abuse comorbidity, impulsivity, depressive severity, and manic severity. Specifically, we hypothesized that study participants with the following characteristics would be at a higher risk of missing visits: male gender, younger, no college education, low quality of life, high psychosocial functioning impairment, substance abuse comorbidity, high impulsivity, and more severe manic and depressive symptoms [22] [23] [24] . For each missing data model, we included a log transformation of time.
To estimate the weights, we modeled the numerator and denominator probabilities separately. We fit separate pooled logistic regression models to estimate the numerator and denominator probabilities, conditional on only the most recent covariate measurements. After fitting these models and determining the probability estimates, we calculated each participant's cumulative probability at any given study visit by multiplying the current probability by the probability at the previous study visit. Finally, Intent to Attend in a randomized trial 497 we divided the numerator probability by the denominator probability to obtain the stabilized weight estimate. This procedure is similar to that of Hernán et al. [5] and is further outlined in Appendix 1 (see supplementary data). The baseline weights were defined as 1, since by design, every patient analyzed was observed at baseline. We assessed model fit using a Hosmer-Lemeshow Goodness-of-Fit Test.
IPAW outcome model
The primary hypothesis of LiTMUS was that patients randomized to the adjunct lithium group would experience greater improvement in mean bipolar severity over time compared to those not receiving lithium. Although the study protocol prespecified a linear change in mean bipolar severity over time, we determined that a log transformation of time fit the data much better. We used weighted GEEs to fit marginal models, which assumed an identity link function, a normal variance, and an independent working correlation structure (see Appendix 1 in supplementary data). As opposed to unweighted GEEs, which are robust to covariance model misspecification, IPAW has been shown to produce biased estimates of longitudinal treatment effects unless one uses the independent working correlation structure [25] . Each observation was weighted using the estimates from the missing data models. The dependent variable was bipolar severity, while the independent variables were log-time and the randomized treatment group-by-log-time interaction. This model was used to estimate the difference in bipolar severity between treatment groups at 6 months as well as the associated 95% confidence interval (based on empirical standard error estimates).
A few other models were fit for comparison. First, we removed the weights from the analysis described above and fit the unweighted marginal model. We also fit two mixed-effects linear regression models with random intercepts and slopes: the first included time and the group-by-time interaction, while the second also included a patient's previous intent as a covariate (as suggested by Leon et al. [1] ).
Assumptions
Some important assumptions underlie our methods. First, in our missing data models, we assume that every subject has a positive probability of being observed at each visit (i.e., no individual is considered a dropout). By design, LiTMUS patients were allowed to return to the study regardless of how many study visits they missed, so this modeling strategy is reasonable. The results of our weighted analysis are also based on the assumption that the probability of missing is independent of current bipolar severity as well as any previously unobserved variables, given the patient's entire observed history of outcomes and covariates. Although this assumption is not empirically testable, the Intent to Attend item acts as a surrogate for unmeasured covariates in the missing data models; thus, its inclusion strengthens the validity of this assumption.
Software
The data analysis was done using SAS 9.2 (SAS Institute, Cary, NC, USA). The figures were created using R 2.14.2 (http://www.R-project.org/). See Appendix 1 in the supplementary data for select SAS code of this analysis.
Results
Intent to Attend and missing data in LiTMUS
Overall, a majority of patients reported high intentions of attending their next study visit. Over 90% of all responses were an 8 or above, suggesting a high likelihood that most patients would attend their next assessment session. Over the entire study, the mean intent was 8.3 with a standard deviation of 1.1. Despite this overall consistency, responses did span the entire range of the Intent to Attend scale, with 29 cases of intent lower than 5. Table 1 shows the frequency of missing data (intermittent and monotonic) at each study visit. Out of a total of 2547 possible outcome measurements (283 patients, 9 visits per patient), only 284 were missed (11%). A total of 91 patients (32%) contributed to these missed visits; thus, almost 70% of patients attended every study visit. Of those 91 patients who missed, 45 experienced only intermittent missing data, 38 experienced only monotonic missing data, and 8 experienced both (i.e., returned after missing at least once, but were later lost to follow up). The high number of patients who returned after a missed study visit is not surprising, as this study allowed participants to miss a visit and still remain in the study.
Fitting the marginal model from Equation 1, we found that a patient's intent at the previous study visit was a significant predictor of missed study visits (p-value = 0.002). Specifically, every 1-unit increase in a patient's intent was associated with a 25% increase in the odds of attending the subsequent visit. In other words, as a patient's intentions decreased, the probability of missing the next visit increased. The intent-by-time interaction was nonsignificant, indicating that the effect of intent did not change over time.
Probabilities of missed visits and stabilized weights
The parameter estimates from our missing data models (pooled logistic regressions) can be interpreted as adjusted hazard ratios [3, 6] , such that a ratio greater than 1 reflects a higher probability of attending a study visit and a ratio less than 1 reflects a higher probability of not attending. The variables included in our missing data models and their corresponding hazard ratios are listed in Table 2 . In both models, we confirmed that higher previous intent scores significantly increased a patient's hazard of being observed, adjusting for all other covariates. In addition, we found that a previously missed visit, male gender, and higher manic severity were significant predictors of missing outcome measurements. Both missing data models seemed to fit the data well, with non-significant goodness-of-fit statistics (see Table 2 ). Figure 2 shows the distributions of the estimated probabilities for our second missing data model. The probabilities correspond to the denominator of the stabilized weights (see Equation 2 ). It is clear from Figure 2 that, in general, the probability of being observed decreases over time. The probabilities ranged from 0.02 to 0.98 (excluding the baseline probabilities, which are all defined as 1). Results were similar when considering the distributions of the stabilized weights. The bottom of Table 2 shows that the weights had a large range and their distributions were positively skewed. Similar to what was expected, the weights were primarily centered around 1 and increased in variability over time [5] (not shown).
LiTMUS primary study hypothesis
In Figure 3 , we plotted the crude sample bipolar severity means by treatment group and study visit over the entire range of the scale. On average, patients in both groups seem to improve (decrease) in bipolar severity over the study; however, it is not clear from the crude means whether the lithium group experienced greater improvement compared to those not receiving lithium.
In Table 3 , we report the model-based change from baseline in each group as well as the 6-month differences in bipolar severity. In Figure 4 , we compare the mean estimates of three of our models: the unweighted marginal model (GEE: unweighted), the mixed model with previous intent as a covariate (MIXED: with intent), and the weighted marginal model including all covariates (GEE: IPAW model 2). We focus in on a smaller range of the scale to show the model differences.
Regardless of the model, we confirm that both treatment groups improve significantly over the course of the study (see Table 3 ). Testing each of our models, we did not find statistically significant differences between the treatment groups at 6 months; however, the weighted models resulted in much larger differences than the unweighted model and both mixed models (see Table 3 and Figure 4 ). We found that, although non-significant, the adjunct lithium group seemed to experience less improvement over the 24 weeks.
Discussion
Missing data can be accounted for in many ways, and the best strategy depends on the reason why patient outcomes are not being observed. The Intent to Attend assessment is a simple yet effective way to address missing data in most areas of clinical research. Likewise, IPAW is an intuitive and broadly applicable method that can be used to address many types of missing data. We illustrated how a patient's intent could be used in the context of IPAW to adjust for missed visits in a randomized trial. A patient's time-varying intent was found to be a necessary predictor of study attendance, even when adjusting for other predictors of missing data. Compared to an unweighted analysis, IPAW yielded larger differences in disease severity change over time between treatment groups.
IPAW is not the only way to use self-rated intent to address missing data. We also considered including intent as a covariate in this analysis. In certain cases, covariate adjustment may introduce bias into the effect of interest [6, 9] ; however, it may be easier to implement into standard statistical software. Intent to Attend in a randomized trial 499
Another approach could involve multiple imputation. In one simulation, Carpenter and Kenward [26] found that although multiple imputation was more efficient than IPAW under a correctly specified missing data model, the estimates were extremely biased under model misspecification,
whereas IPAW estimates remained virtually unaffected. We believe that there are many benefits of using IPAW along with the Intent to Attend assessment, but there are other available methods. Thus, further research into these alternatives is warranted and encouraged. We must consider the limitations of this study. Given that LiTMUS had a relatively small proportion of missing outcome data (11%), the effects of adjusting for it may have been attenuated. This method would have a larger effect in studies where missing data are more prevalent. In addition, semiparametric methods, like IPAW, can be less efficient and less powerful than maximum likelihood or Bayesian estimators, given that the parametric model is well specified [2, 7] . Our results are based on the assumption that the IPAW missing data models were correctly specified. Although correct model specification is a strong assumption, it is likely less restrictive than assuming that the missing data are ignorable without any type of adjustment. Another concern is that there may be other predictors of study attendance not included in the analysis; however, our models included those supported by the literature and those that would be most relevant among this patient population. Also, we included the Intent to Attend item, which acts as a surrogate for unmeasured predictors of study visit attendance. Another possible drawback is that we assumed the probability of missing depended on the patient's Hazard ratio greater than 1 reflects a higher probability of retention; hazard ratio less than 1 reflects a higher probability of attrition. presence (or absence) at the previous visit, allowing this method to incorporate intermittent missing data. This approach does not differentiate between dropouts and those who simply miss one visit; instead, it assumes that each subject has a positive probability of being observed at each study visit. In LiTMUS, patients were allowed to return to the study at any time, regardless of how many previous visits they missed. Thus, in this case, we believe this approach was reasonable. Despite its limitations, this analysis has a number of strengths. This is the first implementation and analysis of the Intent to Attend assessment in a randomized trial. We confirmed that this item predicted a patient's actual study attendance and could be used in a sensitivity analysis of missing data. This article is also one of the few descriptions and implementations of IPAW in the setting of a psychiatric randomized trial. Another strength of this study is that the LiTMUS database included nearly complete data on numerous variables, allowing us to incorporate various predictors into our missing data models. Furthermore, psychiatric research is an area in which the Intent to Attend assessment may prove to be especially useful. Even among bipolar patients, who frequently experience severe mood swings, we found that their self-rated intentions helped to predict their actual study attendance. Compared with other questionnaires that are often employed in psychiatric studies, this item adds little burden both to investigators and study participants. In addition, the benefits of this assessment go beyond its use in a sensitivity analysis. In LiTMUS, for example, if a patient reported a low intent score, investigators inquired into the patient's motivation for early termination. This helped investigators understand the causal mechanisms behind missed visits, as well as allowed for adjustments to be made to prevent the patient from dropping out of the study.
In summary, we demonstrated how a simple selfreport measure, the Intent to Attend assessment, Intent to Attend in a randomized trial 501
